Topics

Life Sciences Ontario Company Profile

09:03 EST 21st January 2020 | BioPortfolio

Fusion Pharmaceuticals is a biopharmaceutical company located in Hamilton, Ontario, focused on becoming the leader in the targeted alpha therapy field. Fusion, which is a spin out from McMaster University’s Centre for Probe Development and Commercialization (CPDC), exploits its unique expertise in linking medical isotopes to targeting molecules to create highly effective cancer therapeutics. In addition to its lead program, FPX-01, with a clinical trial planned for early 2018, Fusion is expanding its pipeline of products through a proprietary protein discovery platform, in-licensing targeting molecules and forming new strategic partnerships.


News Articles [2239 Associated News Articles listed on BioPortfolio]

Accelerating growth for Ontario life sciences

Traditional manufacturing and production industries that have historically fuelled economic prosperity are facing significant headwinds on growth, difficulty in retaining investment and attracting new...

Life Sciences Ontario: Paul Lucas. Promoting Ontario's vibrant and diverse life sciences sector

In this episode of PharmaTelevision News Review, filmed at Bio Conference 2013, in Chicago, USA, Fintan Walton talks to Paul Lucas of Life Sciences Ontario

BioTalent Canada and Life Sciences Ontario Expand Partnership with the Release of the PetriDish™ Life Sciences Ontario Job Board

Today, BioTalent Canada and Life Sciences Ontario (LSO) announced the launch of The PetriDish™ Life Sciences Ontario job board, providing companies in one of Canada’s largest ...

MediPharm Labs Founders Named EY Ontario Entrepreneur of the Year Award Finalists in the Health & Life Sciences Category

BARRIE, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, resea...

5 Ways To Keep Your Life Sciences Startup From Becoming Theranos

Bio-IT World Contributed Commentary | Transparency is critical for all industries these days, but especially for the life sciences sector. When it comes to innovative services and products from e...

BioSpace Announces the 2019 Top 30 Life Sciences Ideal Employers

According to the second biennial 2019 Life Sciences Ideal Employer Report by BioSpace, the top three most important attributes cited by life sciences professionals around the world are the opportunity...

Embracing the Digital Future: The Challenges of Managing Information in Life Sciences

Managing information is critically important to life sciences companies. Creating new products can take years of trial and error and every step in the process must be documented thoroughly—not only ...

New NYC Life Sciences Campus Expected to Provide 1,400 Jobs

New York City’s life sciences community continues to boom as Deerfield Management Company, in partnership with LifeSci NYC and the New York City Economic Development Corporation, announced an initia...

Drugs and Medications [65 Associated Drugs and Medications listed on BioPortfolio]

Mondoxyne [oculus innovative sciences]

Mondoxyne NL 50mg

Mondoxyne nl 100mg [oculus innovative sciences]

Monodoxyne NL 100mg

Deltasone [oculus innovative sciences]

Deltasone 20mg prednisone tablets

Atorvastatin calcium [northwind pharmaceuticals]

NA

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir dis...

PubMed Articles [2944 Associated PubMed Articles listed on BioPortfolio]

The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study.

Naloxone is a life-saving antidote for opioid overdoses. In June 2016, the Ontario government implemented the Ontario Naloxone Program for Pharmacies (ONPP) to enhance access to naloxone.

Outcomes of uninsured midwifery clients in Ontario, Canada: A retrospective cohort study.

To describe the characteristics, health service utilization, and clinical outcomes of Ontario residents who are not covered by the Ontario Health Insurance Plan and receive services from Ontario midwi...

ALBAN FREI, Sichtbare Netzwerke. Forschungspolitik und Life-Sciences zwischen 1990 und 2016 in der Schweiz. Eine Fallstudie zu SystemsX.ch, Zürich: Chronos Verlag, 2018, 272 pp., CHF 38.00/EUR 38.00.

The Impact of the Long-term Care Homes Act and Public Reporting on Physical Restraint and Potentially Inappropriate Antipsychotic Use in Ontario's Long-term Care Homes.

We report on the impact of two system-level policy interventions (the Long-Term Care Homes Act [LTCHA] and Public Reporting) on publicly reported physical restraint use and non-publicly reported poten...

Actor-partner effects of childhood disadvantage on later life subjective well-being among individuals in coresidential unions.

Prior research on cumulative disadvantage has primarily focused on individuals' own childhood adversity for their later-life outcomes. Nevertheless, partner's childhood disadvantage may also shape res...

Clinical Trials [2931 Associated Clinical Trials listed on BioPortfolio]

Continuity of Care and Outcomes After Discharge From Hospital

1. INTRODUCTION: Continuity of care (COC) occurs when separate elements of patient care are connected. COC is made up primarily of Continuity of Provider (COP) and Continuity of Informat...

Access to Infertility Services: Clinic Perspective

Since the identification of the human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS) in the 1980s, there have been significant advances made in the manageme...

Advance Care Planning at London Health Sciences Centre

All patients admitted to London Health Sciences Centre (LHSC) are asked to indicate their preferences for CPR (cardiopulmonary resuscitation) and other life-sustaining treatments that nece...

Early Psychosis Intervention - Spreading Evidence-based Treatment

Implementation of 'NAVIGATE' in Ontario aims to help youth and emerging adults suffering from a first episode of psychosis. Although Ontario already has early psychosis intervention progra...

The PIP-STOPP Study

The overall objective of the present study will be to describe the occurrence of Potentially Inappropriate Prescribing (PIP) in Ontario's elderly (>65 yrs) population, assess the health an...

Companies [2253 Associated Companies listed on BioPortfolio]

Ontario Bioscience Innovation Organization

The Ontario Bioscience Innovation Organization (OBIO®) is a private sector, membership-based organization that is Ontario’s leading advocate for the life sciences sector. ...

Ontario, Canada

Ontario, Canada’s business environment is designed for global success. Ontario is an efficient North American hub for international investment and trade. It offers direct acc...

Gilead Sciences Canada, Inc.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to...

Life Sciences Pennsylvania

Life Sciences Pennsylvania is the statewide trade association for the life sciences in Pennsylvania and serves as a catalyst to ensure Pennsylvania is a global leader in the life ...

Blackstone Life Sciences

Blackstone Life Sciences is a private investment platform with capabilities to invest across the life-cycle of companies and products within the key life science sectors. By combi...

More Information about "Life Sciences Ontario" on BioPortfolio

We have published hundreds of Life Sciences Ontario news stories on BioPortfolio along with dozens of Life Sciences Ontario Clinical Trials and PubMed Articles about Life Sciences Ontario for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Life Sciences Ontario Companies in our database. You can also find out about relevant Life Sciences Ontario Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record